Results 51 to 60 of about 145,557 (152)
The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors
British Journal of Pharmacology, Volume 182, Issue S1, Page S24-S151, December 2025.The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander +206 more
wiley +1 more source
A non-imaging high throughput approach to chemical library screening at the unmodified adenosine-A3 receptor in living cells [PDF]
, 2017 Recent advances in fluorescent ligand technology have enabled the study of G protein-coupled receptors in their native environment without the need for genetic modification such as addition of N-terminal fluorescent or bioluminescent tags.
Antonioli +59 more
core +1 more source
Topical Anesthesia and Olfactory Capability: A Pilot Study
Laryngoscope Investigative Otolaryngology, Volume 10, Issue 5, October 2025.ABSTRACT Introduction Topical anesthesia (TA) of the nasal fossa has been shown to be sufficient for patient comfort during nasal endoscopy. However, investigators need to know how soon after the administration of TA they can accurately evaluate olfactory capability.
Maxime Fieux +3 more
wiley +1 more source
Acta Anaesthesiologica Scandinavica, Volume 69, Issue 6, July 2025.ABSTRACT Background Several drugs may be used to minimize pain during nasal intubation in awake patients. We hypothesized that the analgesic effect of cocaine would be at least as good (non‐inferior) as that of lidocaine with xylometazoline rated as maximum pain felt during awake nasal intubation of healthy volunteers.
Mo Haslund Larsen +8 more
wiley +1 more source
Research of the attitude towards the application of alternative chemical agents for gingival retraction among the dentists [PDF]
, 2015 Целта на анкетно проучване е да се изследва и анализира познанието и мнението на лекари по дентална медицина относно материалите и методите, използвани за обтуриране на ретрограден кавитет при апикална остеотомия.
Abadzhiev, Metodi +6 more
core +2 more sources
Efficacy and Safety of Oxymetazoline 1% Cream for the Treatment of Mild to Moderate Facial Rosacea
Journal of Cosmetic Dermatology, Volume 24, Issue 4, April 2025.ABSTRACT Introduction Rosacea is a common skin condition that affects the physical and mental health of the patient. The objective of this study was to evaluate the efficacy and safety of oxymetazoline 1% cream, a specific α1A‐adrenoceptor agonist, for the treatment of mild to moderate facial rosacea.
Fatemeh Sajdeh +8 more
wiley +1 more source
The Use of Oxymetazoline 0.1% Ophthalmic Solution for Acquired Blepharoptosis: A Systematic Review
The Laryngoscope, Volume 135, Issue 1, Page 8-14, January 2025.The use of oxymetazoline 0.1% ophthalmic solution significantly improves MRD1 in patients with acquired blepharoptosis. Further studies comparing this treatment in other etiologies of acquired blepharoptosis should be conducted. Objective Oxymetazoline hydrochloride has been shown to be effective in some studies for acquired blepharoptosis and for ...
Mary Newland +3 more
wiley +1 more source
Ferulic Acid in the Treatment of Papulopustular Rosacea: A Randomized Controlled Study
Journal of Cosmetic Dermatology, Volume 24, Issue 1, January 2025.ABSTRACT Background Rosacea is a chronic inflammatory skin disease characterized by flushing, erythema, papules, and pustules on the central face. It affects patient appearance and is noted for its chronicity, recurrence, and resistance to treatment. Effective rosacea treatment requires repairing the skin barrier, reducing inflammation, and promoting ...
Xing Wang +9 more
wiley +1 more source
Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A
Dermatology Research and Practice, Volume 2025, Issue 1, 2025.Blepharoptosis as an Aesthetic Complication Eyelid ptosis, or blepharoptosis, following esthetic treatment of the upper third with botulinum toxin Type A (BoNT‐A) is a complication with a variable incidence depending on the injector’s experience. Among unexperienced injectors, it ranges from 2.5% to 5.4% and approximately 0.51% to 1% in experienced ...
Rengifo-Palacios Jaime Alberto +4 more
wiley +1 more source
Application of α-adrenomimetic decongestants as chemical agents for gingival retraction [PDF]
, 2015 PURPOSE: The purpose of this study is to observe, compare and evaluate the effect of two α-adrenomimetic decongestants which are clinically approved nasal and eye drops - 0,05% xylometazoline hydrochloride and 0,05% tetrahydrozoline hydrochloride, when ...
Abadjiev, Metodi +5 more
core +2 more sources